118 related articles for article (PubMed ID: 27556820)
1. High Expression of Vimentin is Associated With Progression and a Poor Outcome in Glioblastoma.
Zhao J; Zhang L; Dong X; Liu L; Huo L; Chen H
Appl Immunohistochem Mol Morphol; 2018; 26(5):337-344. PubMed ID: 27556820
[TBL] [Abstract][Full Text] [Related]
2. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
3. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme.
Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q
J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323
[TBL] [Abstract][Full Text] [Related]
4. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
5. SEMA6A is a prognostic biomarker in glioblastoma.
Zhao J; Tang H; Zhao H; Che W; Zhang L; Liang P
Tumour Biol; 2015 Nov; 36(11):8333-40. PubMed ID: 26014517
[TBL] [Abstract][Full Text] [Related]
6. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.
Fowler A; Thomson D; Giles K; Maleki S; Mreich E; Wheeler H; Leedman P; Biggs M; Cook R; Little N; Robinson B; McDonald K
Eur J Cancer; 2011 Apr; 47(6):953-63. PubMed ID: 21196113
[TBL] [Abstract][Full Text] [Related]
7. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and neuroimaging findings in 12 cases of recurrent glioblastoma with communicating hydrocephalus.
Onuma K; Ishikawa E; Matsuda M; Hirata K; Osuka S; Yamamoto T; Masumoto T; Zaboronok A; Matsumura A
Neurol Med Chir (Tokyo); 2013; 53(7):474-81. PubMed ID: 23883558
[TBL] [Abstract][Full Text] [Related]
9. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093
[TBL] [Abstract][Full Text] [Related]
10. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
11. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
Cheng P; Ma Y; Gao Z; Duan L
Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression.
Lin CY; Yang ST; Shen SC; Hsieh YC; Hsu FT; Chen CY; Chiang YH; Chuang JY; Chen KY; Hsu TI; Leong WC; Su YK; Lo WL; Yeh YS; Patria YN; Shih HM; Chang CC; Chou SY
Mol Oncol; 2018 May; 12(5):756-771. PubMed ID: 29603594
[TBL] [Abstract][Full Text] [Related]
13. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
14. Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells.
Noh H; Yan J; Hong S; Kong LY; Gabrusiewicz K; Xia X; Heimberger AB; Li S
Oncotarget; 2016 Nov; 7(44):72021-72032. PubMed ID: 27713131
[TBL] [Abstract][Full Text] [Related]
15. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines.
Jung TY; Jung S; Ryu HH; Jeong YI; Jin YH; Jin SG; Kim IY; Kang SS; Kim HS
J Neurosurg; 2008 Aug; 109(2):273-84. PubMed ID: 18671640
[TBL] [Abstract][Full Text] [Related]
16. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
18. High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme.
Liu B; Pang B; Liu H; Arakawa Y; Zhang R; Feng B; Zhong P; Murata D; Fan H; Xin T; Zhao G; Liu W; Guo H; Luan L; Xu S; Miyamoto S; Pang Q
Pathol Res Pract; 2015 Aug; 211(8):596-600. PubMed ID: 26092597
[TBL] [Abstract][Full Text] [Related]
19. The impact of inpatient rehabilitation on function and survival of newly diagnosed patients with glioblastoma.
Roberts PS; Nuño M; Sherman D; Asher A; Wertheimer J; Riggs RV; Patil CG
PM R; 2014 Jun; 6(6):514-21. PubMed ID: 24384359
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma multiforme-report of 267 cases treated at a single institution.
Stark AM; Nabavi A; Mehdorn HM; Blömer U
Surg Neurol; 2005 Feb; 63(2):162-9; discussion 169. PubMed ID: 15680662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]